Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares M, de Souza GA, Fidalgo TM, Araujo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Silva Ullmann O, Sloan T, Sloan KP LA (2022) GLP-1a: going beyond traditional use
Semaglutide is available in both injectable and oral forms
What the evidence supports In the EBCTCG analysis summarized by Oxford Population Health, switching from tamoxifen to an AI in women receiving ovarian suppression reduced breast-cancer recurrence by 21% overall , with the biggest effect during the first five years when treatments differed
We will discuss your weight-loss goals and evaluate any potential risks associated with tirzepatide
It is a biological response to an obesogenic environment that did not exist 100 years ago